The trading price of ABVC BioPharma Inc (NASDAQ:ABVC) closed higher on Tuesday, April 23, closing at $1.35, 29.81% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $9.60 and a 52-week low of $0.67. Over the past month, the stock has gained 26.17% in value.
ABVC BioPharma Inc, whose market valuation is $14.26 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0 per share this quarter, however they have predicted annual earnings per share of $0 for 2023 and $0 for 2024.
Analysts have forecast the company to bring in revenue of -$ for the current quarter, with the likely lows of $300k and highs of $300k. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2023 is $152k. The company’s revenue is forecast to drop by -84.30% over what it did in 2023.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of ABVC BioPharma Inc no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ABVC has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently Hold.
A quick review shows that ABVC’s price is currently 15.09% off the SMA20 and 12.73% off the SMA50. The RSI metric on the 14-day chart is currently showing 61.21, and weekly volatility stands at 17.83%. When measured over the past 30 days, the indicator reaches 11.42%. ABVC BioPharma Inc (NASDAQ:ABVC)’s beta value is currently sitting at 0.80, while the Average True Range indicator is currently displaying 0.12.
To see how ABVC BioPharma Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ABVC stock’s performance was 29.81% in the latest trading, and -79.85% in the past year.
An evaluation of the daily trading volume of ABVC BioPharma Inc (NASDAQ:ABVC) indicates that the 3-month average is 737.10K.
Currently, records show that 10.56 million of the company’s shares remain outstanding. The insiders hold 17.84% of outstanding shares, whereas institutions hold 1.05%. However, since the stock’s price has seen 16.38% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
